State of Tennessee Treasury Department decreased its position in shares of Aetna Inc. (NYSE:AET) by 19.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 448,912 shares of the company’s stock after selling 108,902 shares during the quarter. State of Tennessee Treasury Department owned 0.14% of Aetna worth $71,382,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. BlackRock Inc. lifted its position in Aetna by 3,374.9% during the first quarter. BlackRock Inc. now owns 30,712,219 shares of the company’s stock worth $3,917,344,000 after purchasing an additional 29,828,390 shares during the period. Capital World Investors lifted its position in Aetna by 8.9% during the second quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock worth $3,153,358,000 after purchasing an additional 1,688,767 shares during the period. FMR LLC lifted its position in Aetna by 73.8% during the second quarter. FMR LLC now owns 13,736,800 shares of the company’s stock worth $2,085,659,000 after purchasing an additional 5,833,567 shares during the period. Janus Henderson Group PLC lifted its position in Aetna by 9,446.2% during the second quarter. Janus Henderson Group PLC now owns 4,328,900 shares of the company’s stock worth $657,255,000 after purchasing an additional 4,283,553 shares during the period. Finally, AQR Capital Management LLC lifted its position in Aetna by 26.0% during the first quarter. AQR Capital Management LLC now owns 3,639,077 shares of the company’s stock worth $464,165,000 after purchasing an additional 751,166 shares during the period. 91.06% of the stock is owned by institutional investors and hedge funds.
Aetna Inc. (AET) traded down $0.34 during trading on Monday, hitting $176.65. The stock had a trading volume of 1,213,399 shares, compared to its average volume of 2,934,238. Aetna Inc. has a one year low of $105.39 and a one year high of $184.98. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.53 and a quick ratio of 0.53. The firm has a market capitalization of $57,716.44, a P/E ratio of 17.33, a P/E/G ratio of 1.61 and a beta of 0.61.
Aetna (NYSE:AET) last released its quarterly earnings data on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.06 by $0.39. Aetna had a return on equity of 21.84% and a net margin of 2.93%. The company had revenue of $14.99 billion during the quarter, compared to the consensus estimate of $15.12 billion. During the same quarter in the prior year, the firm posted $2.07 earnings per share. The firm’s revenue was down 5.0% compared to the same quarter last year. equities research analysts predict that Aetna Inc. will post 9.79 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Thursday, October 12th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date was Wednesday, October 11th. Aetna’s dividend payout ratio is presently 37.04%.
In other Aetna news, President Karen S. Lynch sold 15,271 shares of the stock in a transaction that occurred on Monday, September 18th. The shares were sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the completion of the sale, the president now owns 64,261 shares of the company’s stock, valued at approximately $10,404,498.51. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Margaret M. Mccarthy sold 10,288 shares of the stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the sale, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at approximately $5,465,734.55. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.
Several equities research analysts recently weighed in on AET shares. BMO Capital Markets upped their price objective on shares of Aetna from $175.00 to $200.00 and gave the stock a “market perform” rating in a research report on Friday, October 27th. Argus reaffirmed a “buy” rating and set a $185.00 price objective (up previously from $165.00) on shares of Aetna in a research report on Tuesday, September 12th. Zacks Investment Research raised shares of Aetna from a “hold” rating to a “strong-buy” rating and set a $184.00 price objective for the company in a research report on Wednesday, October 25th. BidaskClub cut shares of Aetna from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 19th. Finally, Morgan Stanley upped their price objective on shares of Aetna from $172.00 to $179.00 and gave the stock an “overweight” rating in a research report on Thursday, August 17th. Eleven equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $170.34.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
What are top analysts saying about Aetna Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Aetna Inc. and related companies.